Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CASP6 | P55212 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 5/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.53 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.52 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.52 |
| ▸ | CLK2 | P49760 | 1/20 | 0.52 |
| ▸ | SRPK1 | Q96SB4 | 1/20 | 0.52 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.52 |
| ▸ | KDM5A | P29375 | 1/20 | 0.52 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.52 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29365815 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MEN1KMT2APOLBCASP6 | |
| Hydrochloric Acid SCHEMBL7001071 | 0.98 | ALDH1A1 (0.55) | ALDH1A1MEN1KMT2APOLBCASP6 | |
| SCHEMBL261380 | 0.85 | CTNNB1 (0.65) | ALDH1A1MEN1KMT2ATDP1MAOB | |
| SCHEMBL30270547 | 0.85 | CTNNB1 (0.65) | ALDH1A1MEN1KMT2ATDP1MAOB | |
| SCHEMBL20187143 | 0.84 | MAOB (0.58) | ALDH1A1MEN1KMT2APOLBCASP6 | |
| Hydrochloric Acid SCHEMBL1665151 | 0.84 | CTNNB1 (0.63) | ALDH1A1MEN1KMT2ATDP1MAOB | |
| SCHEMBL7378385 | 0.84 | MAOB (0.55) | ALDH1A1MEN1KMT2AMAOBKDM4E | |
| SCHEMBL30194367 | 0.84 | MAPT (0.68) | ALDH1A1MEN1KMT2AMAOBKDM4E | |
| SCHEMBL475069 | 0.84 | AR (0.63) | ALDH1A1MEN1KMT2AMAOBKDM4E | |
| SCHEMBL2933207 | 0.84 | MAPT (0.68) | ALDH1A1MEN1KMT2AMAOBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 575 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117417385-A | Preparation method and application of solvent and ammonia response type iron-based complex | 桂林理工大学 | 2024-01-19 | — | — | CN | claimed |
| CN-117304658-A | Tough multifunctional PBAT-based composite membrane and preparation method and application thereof | 桂林理工大学 | 2023-12-29 | — | — | CN | claimed |
| CN-117285751-A | Solvent and ammonia responsive tough starch/polyvinyl alcohol composite film and preparation method and application thereof | 桂林理工大学 | 2023-12-26 | — | — | CN | claimed |
| CN-117209936-A | Polyvinyl alcohol/starch-based nanocomposite and preparation method and application thereof | 桂林理工大学 | 2023-12-12 | — | — | CN | claimed |
| CN-117209855-A | Ammonia response type multifunctional cellulose nanocrystalline and preparation and application thereof | 桂林理工大学 | 2023-12-12 | — | — | CN | claimed |
| CN-117209788-A | Preparation method and application of multifunctional MOF material with pH response and antibacterial function | 桂林理工大学 | 2023-12-12 | — | — | CN | claimed |
| CN-117050300-A | Polylysine-based polymer adjuvant material, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2023-11-14 | — | — | CN | claimed |
| US-20220127254-A1 | INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER | MERCK PATENT GMBH (DE) | 2022-04-28 | — | — | US | claimed |
| CN-113603886-A | Polyethyleneimine derivative and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2021-11-05 | — | — | CN | claimed |
| CN-110128347-A | A kind of synthetic method of 1- methyl-1 H- indazole -6- formic acid | 韶远科技（上海)有限公司 | 2019-08-16 | — | — | CN | claimed |
| WO-2026107076-A1 | CDK2 INHIBITOR COMPOUNDS | ALEKSIA THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| CN-122036615-A | Indazole hydrazide compound and preparation method and application thereof | 南京农业大学 | 2026-05-15 | — | — | CN | disclosed |
| US-12577243-B2 | Monoacylglycerol lipase modulators | JANSSEN PHARMACEUTICA NV (BE) | 2026-03-17 | — | — | US | disclosed |
| EP-3856178-B1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2026-03-11 | — | — | EP | disclosed |
| US-12552770-B2 | Compounds for treating respiratory disease | TMEM16A LIMITED (GB) | 2026-02-17 | — | — | US | disclosed |
| WO-1998009961-A1 | INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE (PDE) TYPE IV AND THE PRODUCTION OF TUMOR NECROSIS FACTOR (TNF) | PFIZER INC. (US) | 1998-03-12 | — | — | WO | disclosed |
| EP-0242167-B1 | HETEROCYCLIC CARBOXAMIDES | ICI AMERICAS INC. (US) | 1991-11-27 | — | — | EP | disclosed |
| US-4898863-A | Heterocyclic carboxamides | ICI AMERICAS INC. (US) | 1990-02-06 | — | — | US | disclosed |
| CN-87103504-A | Heterocyclic carboxamide | — | 1987-12-09 | — | — | CN | disclosed |
| EP-0242167-A2 | Heterocyclic carboxamides | ICI AMERICAS INC. (US) | 1987-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552770-B2 | Compounds for treating respiratory disease | TMEM109, SCN1A, SLC16A1 | ALDH1A1 596/4885MEN1 1176/4885KMT2A 1602/4885 |
| US-12577243-B2 | Monoacylglycerol lipase modulators | MGLL, LPL, FAAH | ALDH1A1 587/4885MEN1 4537/4885KMT2A 3729/4885 |
| US-20220127254-A1 | INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER | KIT, TNNI3K, CILK1 | ALDH1A1 421/4885MEN1 1604/4885KMT2A 1369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.